Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings].
作者信息
Mullen P W
出版信息
Br J Pharmacol. 1979 Nov;67(3):470P-472P.
Abstract
摘要
相似文献
1
2
[Effects on the lymphreticular system and inhibition of liver microsomaal cytochrome P-450 in mice administered Priopionibacterium acnes (Corynebacterium parvum) bacterin].
Cesk Epidemiol Mikrobiol Imunol. 1985 Mar;34(2):100-6.
3
Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat.用短小棒状杆菌刺激库普弗细胞可降低大鼠体内一些细胞色素P450依赖的活性，并减轻对乙酰氨基酚和四氯化碳诱导的肝损伤。
Toxicol Appl Pharmacol. 1994 Nov;129(1):36-45. doi: 10.1006/taap.1994.1226.
4
Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice.苯妥英钠药代动力学的遗传差异。近交系小鼠的体内清除率和体外代谢情况。
Dev Pharmacol Ther. 1980;1(5):281-304.
5
Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.苯妥英的代谢活化：细胞色素P-450、谷胱甘肽、年龄及性别在大鼠和小鼠中的作用
Res Commun Chem Pathol Pharmacol. 1988 Feb;59(2):173-90.
6
Effects of Corynebacterium parvum vaccine on drug metabolism in the mouse.
Dev Biol Stand. 1977;38:427-30.
7
Effects of interferon on drug metabolism.
Tex Rep Biol Med. 1981;41:363-9.
8
Enhanced resistance of Corynebacterium parvum-treated mice to infection by bacteria.
J Med Microbiol. 1972 Feb;5(1):Pvii.
9
Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.
Drug Metab Dispos. 1983 Jan-Feb;11(1):21-4.
10
[Immunotherapy with Corynebacterium parvum in experimental influenza virus infections and mixed infections in mice].
Pol Tyg Lek. 1986 May 12;41(19):619-23.
本文引用的文献
1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Studies on the metabolism of diphenylhydantoin in mice.
J Pharmacol Exp Ther. 1969 May;167(1):77-90.
3
Inhibition of diphenylhydantoin elimination by its major metabolite.
Res Commun Chem Pathol Pharmacol. 1972 Sep;4(2):297-306.
4
Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.通过拟合米氏方程的积分形式来解释苯妥英血浆水平的剂量依赖性下降。
Res Commun Chem Pathol Pharmacol. 1972 May;3(3):455-66.
5
Novel metabolic products of cyclophosphamide in human urine.
Biochem Pharmacol. 1975 Jun 15;24(11-12):1233-5. doi: 10.1016/0006-2952(75)90068-4.
6
Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum.
Cancer Res. 1976 Dec;36(12):4425-8.
7
Quantitative determination of cytochrome P-450 in rat liver homogenate.大鼠肝脏匀浆中细胞色素P-450的定量测定。
Anal Biochem. 1976 Oct;75(2):596-603. doi: 10.1016/0003-2697(76)90114-7.
8
Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay.
Drug Metab Rev. 1976;5(2):295-310. doi: 10.3109/03602537609029981.
9
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.
Biochem Pharmacol. 1976 Jul 1;25(13):1529-35. doi: 10.1016/0006-2952(76)90072-1.
10
Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.
J Pharm Pharmacol. 1979 Feb;31(2):100-4. doi: 10.1111/j.2042-7158.1979.tb13441.x.
Zotero 插件